The injectable drug and others like it have become extremely popular in recent years as a way to manage diabetes and lose a ...

Plenty of folks have been using GLP-1s — generic versions of popular weight loss drugs such as Ozempic and Zepbound — to jump ...

Mughal ruler Aurangzeb’s grave in Maharashtra’s Khuldabad has become a target of fringe right-wing groups, who are demanding its demolition. The 17th-century emperor is once again back in the news and ...

Television and film producer, Ektaa Kapoor is not someone to mince her words. She has revealed the real culprit behind poor ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo ...

Fact checked by Nick Blackmer “Microdosing” GLP-1 drugs like Ozempic is gaining attention on social media, but doctors say it ...

Drug compounders are moving to block the FDA’s decision that Novo Nordisk A/S’s weight loss drug is no longer in shortage, ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Also in today’s newsletter, Trump sanctions Chinese companies over Iran oil shipments, and Foxconn set to sign contract to ...

US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...

The 2.5 mg vial and 5 mg vial will be available at Rs 3,500 and Rs 4,375, respectively. A spokesperson said as Mounjaro ...